[1]秦凤娟,张福娥,王小凤,等.胎儿生长受限患者血清Klotho蛋白、ADMA表达及临床意义[J].陕西医学杂志,2022,51(4):488-491.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.025]
　QIN Fengjuan,ZHANG Fu'e,WANG Xiaofeng,et al.Expression and clinical significance of serum Klotho protein and ADMA in patients with fetal growth restriction[J].,2022,51(4):488-491.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.025]
点击复制

胎儿生长受限患者血清Klotho蛋白、ADMA表达及临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年4期
页码:
488-491
栏目:
临床检验
出版日期:
2022-04-05

文章信息/Info

Title:
Expression and clinical significance of serum Klotho protein and ADMA in patients with fetal growth restriction
作者:
秦凤娟1; 张福娥2; 王小凤3; 贾彦海4
(1.宝鸡市人民医院产科,陕西 宝鸡 721000; 2.宝鸡市人民医院妇科,陕西 宝鸡 721000; 3.西北妇女儿童医院产科,陕西 西安 710061; 4.宝鸡市人民医院检验科,陕西 宝鸡 721000)
Author(s):
QIN Fengjuan; ZHANG Fu'e; WANG Xiaofeng; JIA Yanhai
(Department of Obstetrics,Baoji People's Hospital,Baoji 721000,China)
关键词:
胎儿生长受限;  Klotho蛋白;  不对称性二甲基精氨酸;  妊娠结局;  联合诊断;  新生儿体重指数
Keywords:
Fetal growth restriction;  Klotho protein;  Asymmetric dimethylarginine;  Pregnancy outcome;  Combined diagnosis;  Neonatal weight
分类号:
R 714.2
DOI:
DOI:10.3969/j.issn.1000-7377.2022.04.025
文献标志码:
A
摘要:
目的:研究胎儿生长受限(FGR)患者血清Klotho蛋白、不对称性二甲基精氨酸(ADMA)的表达及临床意义。方法:纳入妊娠早期孕妇180例,均随访至妊娠结局,根据是否发生FGR,分为FGR组和对照组,各90例。测定两组血清Klotho蛋白、ADMA水平,使用ROC曲线分析Klotho蛋白、ADMA、Klotho蛋白联合ADMA对FGR的诊断价值。记录两组的妊娠结局和FGR严重程度指标,使用Pearson检验分析Klotho蛋白、ADMA与分娩孕周、1 min Apgar评分、新生儿体重指数、胎盘质量的相关性。结果:FGR组Klotho蛋白水平低于对照组,ADMA水平高于对照组,差异具有统计学意义(均P<0.05)。Klotho蛋白联合ADMA对FGR的诊断曲线下面积(AUC)高于 Klotho蛋白、ADMA单独诊断,差异具有统计学意义(均P<0.05)。FGR组的1 min Apgar评分、新生儿体重指数和胎盘质量均低于对照组,差异具有统计学意义(均P<0.05)。Klotho蛋白与新生儿体重指数呈明显正相关(P<0.05),与胎盘质量无关(P>0.05)。ADMA与新生儿体重指数和胎盘质量呈明显负相关(均P<0.05)。结论:Klotho蛋白联合ADMA对FGR具有较好的诊断价值,且Klotho蛋白、ADMA均与新生儿体重指数相关。临床中可通过对Klotho蛋白、ADMA的早期检测,评估FGR发生风险,以尽早采取相关措施,促进患者妊娠结局的改善。
Abstract:
Objective:To study the expression and clinical significance of serum Klotho protein and asymmetric dimethylarginine(ADMA)in patients with fetal growth restriction(FGR).Methods:A total of 180 pregnant women in the first trimester were included and followed up to the pregnancy outcome.According to whether FGR occurred,they were divided into FGR group and control group,with 90 cases in each group.The serum Klotho protein and ADMA levels of two groups were measured.ROC curve was used to analyze the diagnostic value of Klotho protein,ADMA,and Klotho protein combined with ADMA for FGR.Pregnancy outcomes and FGR severity indicators in the two groups were recorded.Pearson test was used to analyze the correlation between Klotho protein,ADMA and gestational age,1-minute Apgar score,neonatal body weight,placental weight.Results:The level of Klotho protein in the FGR group was lower than that in the control group,and the level of ADMA was higher than that in the control group(all P<0.05).The area under the curve(AUC)of Klotho protein combined with ADMA for FGR was higher than that of Klotho protein and ADMA alone(all P<0.05).The 1-minute Apgar score,neonatal body weight and placental weight in the FGR group were lower than those in the control group(all P<0.05).Klotho protein was significantly positively correlated with neonatal body weight(P<0.05),but not with placental weight(P>0.05).ADMA was significantly negatively correlated with neonatal body weight and placental weight(all P<0.05).Conclusion:Klotho protein combined with ADMA has good diagnostic value for FGR,and both are related to neonatal body weight.The risk of FGR can be assessed by early detection of Klotho protein and ADMA in clinic,so as to take relevant measures as soon as possible to improve the pregnancy outcome of patients.

参考文献/References:

[1] 廖 杰.母体外周血胎盘标记物对胎儿生长受限的诊断/预测价值[J].检验医学与临床,2019,16(2):272-275.
[2] 段 然,漆洪波.胎儿生长受限的规范化诊断和管理[J].实用妇产科杂志,2021,37(11):801-803.
[3] 宫 婷,潘艳艳.孕11～13+6周子宫动脉频谱与不明原因胎儿宫内生长受限相关性研究[J].陕西医学杂志,2019,48(8):1049-1051.
[4] 刘 蕾,朱锦明,李亚楠,等.胎儿生长受限孕妇血清、胎盘组织中Klotho及VEGFR2蛋白的表达及其临床意义[J].实用医学杂志,2021,37(3):331-335.
[5] 戴 岩,陈 奕.不对称二甲基精氨酸与胎儿生长受限关系的研究进展[J].北京医学,2019,41(11):1037-1039.
[6] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2014:102-103.
[7] 汤 敏,高 洁,张 鑫,等.扩散加权成像评价不同亚型胎儿生长受限胎盘价值的研究[J].陕西医学杂志,2018,47(8):1039-1042.
[8] 孙 丽,吴琦嫦,许亚松,等.早发型胎儿生长受限的胎盘相关因素分析[J].中国妇幼保健,2021,36(24):5782-5785.
[9] 童嘉宁,牛建民.胎儿生长受限的病因学探讨[J].中国实用妇科与产科杂志,2020,36(8):688-692.
[10] 乔 娟,陈瑞欣,漆洪波.胎儿生长受限的预测和预警[J].中国实用妇科与产科杂志,2021,37(11):1092-1095.
[11] 张 媛,朱小静.维持性血液透析患者骨硬化蛋白、Klotho蛋白水平变化及与冠状动脉钙化相关性分析[J].陕西医学杂志,2021,50(10):1246-1249.
[12] 郑静洁,王海欧,周 凯.不对称二甲基精氨酸在子痫前期中的研究进展[J].中国全科医学,2016,19(14):1729-1733.
[13] 吴昌志,余星火.基于妊娠期糖尿病血糖控制效果对Klotho基因表达影响的研究[J].实用中西医结合临床,2020,20(14):4-5,122.
[14] 陈秋玲,曾候霖,蔡 敏,等.不对称性二甲基精氨酸在胎儿生长受限患者胎盘、外周血的表达及其意义[J].中国医师杂志,2015,17(12):1813-1815,1819.
[15] 李发红,韩 娜,江 楠,等.高龄妊娠期高血压疾病产妇胎盘Klotho表达与妊娠结局[J].中国计划生育学杂志,2019,27(10):1304-1307.
[16] 靳紫薇,黄华民.妊娠期糖尿病患者血浆非对称性二甲精氨酸水平变化及其与血浆NO、NOS水平的相关性[J].山东医药,2018,58(3):56-58.
[17] 钟 敏,刘年元,肖慧彬,等.妊娠早、中期血清sEng和ADMA对子痫前期胎盘血管分布及妊娠结局影响[J].中国计划生育学杂志,2019,27(6):747-751.
[18] 邵文佳,王冬雪,万庆宇,等.巨大儿胎盘组织中Klotho mRNA和蛋白的表达及其与新生儿出生体质量的关系[J].中华妇产科杂志,2016,51(6):420-423.
[19] 吴昌志,汤 旭,罗永慧.妊娠期糖尿病患者血清Klotho蛋白水平变化及临床意义[J].实验与检验医学,2021,39(5):1094-1095,1105.
[20] 林 莉,孙 波,王欣昱,等.妊娠期糖尿病孕妇胎盘中Klotho蛋白表达与新生儿出生体重的关联性分析[J].中国生育健康杂志,2020,31(3):250-253.
[21] 段杨平,刘光虹,田兆华,等.妊娠期糖尿病孕妇血浆ADMA、NO、NOS变化及维生素D干预效果研究[J].中国计划生育学杂志,2019,27(4):441-445.

相似文献/References:

[1]宫 婷,潘艳艳.孕11～13+6周子宫动脉频谱与不明原因胎儿宫内生长受限相关性研究[J].陕西医学杂志,2019,(8):1049.
　GONG Ting,PAN Yanyan..Retrospective study on correlation between uterine artery doppler spectrum and IUGR with unknown causes in pregnant women of 11～13+6  gestational weeks[J].,2019,(4):1049.
[2]张 媛,朱小静.维持性血液透析患者骨硬化蛋白、Klotho蛋白水平变化及与冠状动脉钙化相关性分析[J].陕西医学杂志,2021,50(10):1246.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.017]
　ZHANG Yuan,ZHU Xiaojing.Changes of bone sclerostin and Klotho protein levels in maintenance hemodialysis patients and their correlation with coronary artery calcification[J].,2021,50(4):1246.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.017]
[3]洪海燕,刘宇杰,方丽妮,等.超声检查子宫动脉、脐动脉血流参数对胎儿生长受限的诊断价值及临床监测意义[J].陕西医学杂志,2023,52(5):567.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.016]
　HONG Haiyan,LIU Yujie,FANG Lini,et al.Diagnostic value and clinical monitoring significance of blood flow parameters of uterine artery and umbilical artery examined by abdominal ultrasound in fetal growth restriction[J].,2023,52(4):567.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.016]
[4]姚 律,黄小抗,朱 琼.慢性肾衰竭患者并发心血管疾病相关危险因素分析[J].陕西医学杂志,2024,(1):55.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.012]
　YAO Lv,HUANG Xiaokang,ZHU Qiong.Related risk factors affecting cardiovascular diseases in patients with chronic renal failure[J].,2024,(4):55.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.012]

备注/Memo

备注/Memo:
基金项目:中国药学会科普研究重点项目(CMEI2020KPYJ00332)
更新日期/Last Update: 2022-04-07